Genomics Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032

Genomics Industry Prospective:

The global genomics market size was worth around USD 36.25 Billion in 2023 and is predicted to grow to around USD 79.83 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 9.17% between 2024 and 2032.

Request Free Sample

The report analyzes the global genomics market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the genomics industry. 

The report covers a forecast and an analysis of the genomics market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints of the bioinformatics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genomics market on a global and regional level.

In order to give the users of this report a comprehensive view of the genomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

Genomics Market: Growth Drivers

There are a number of important variables that are driving the significant rise that the genomics market is seeing. In the first place, the area has been revolutionized by numerous developments in genomic technologies, such as next-generation sequencing (NGS) and CRISPR-Cas9 gene editing. These technologies have made it possible to analyze genetic information in a more expedient, accurate, and cost-effective manner. These technologies have broadened the breadth of genomic research and applications across a variety of industries, including the medical field, agriculture, and biotechnology, among others. A further factor that has contributed to the expansion of the market is the growing number of government programs and funding support for genetic research initiatives. These factors have also helped to develop collaboration between academic institutions, research organizations, and industry participants.

In addition, the increasing prevalence of genetic disorders and chronic diseases around the globe has led to an increase in the need for personalized medication and diagnostic solutions, which has further fueled the rise of the market. In addition, the growing knowledge among consumers regarding the advantages of genetic testing for illness prevention, diagnosis, and treatment customisation has prompted the adoption of genomic services, which has driven the expansion of the market. Within the context of the genomics market, the dynamic growth trajectory can be attributed to a number of factors, including the confluence of technological innovation, supporting regulatory frameworks, increased disease burden, and expanding consumer awareness.

Genomics Market: Report Scope

Genomics Market: Segmentation

The market for genomics on a global scale has been segmented into three categories: deliverables, applications, and end users. Services and products are included in the genomics market structure, which is based on deliverables. Over the estimated time period, it is anticipated that the goods segment will hold the majority of the market share. This is primarily attributable to the frequent use of instruments and reagents for genomics research, as well as the growing number of research programs that are being carried out by both public and private organizations. There are several sub-segments that fall under the services category. These include NGS-based, core genomics, computational, biomarker translation, and others. Both reagents and instruments are considered to be sub-segments of the products. Epigenomics, functional analysis, biomarker discovery, and pathway analysis are some of the applications that are included in the application sector.

As a result of the enormous amount of sequencing data that was generated in 2018, functional division was the most dominant section of the application market. Chromatin immunoprecipitation (ChIP-Seq), bisulfite sequencing, methylation DNA immunoprecipitation (MeDIP), chromatin accessibility assays, high-resolution melt (HRM), and microarray analysis are the sub-segments that are included in the field of epigenomics. Real-time polymerase chain reaction (PCR), transfection, RNA interference, single nucleotide polymorphism (SNP) analysis, mutational analysis, and microarray analysis are the sub-categories that fall under the functional category.

Real-time polymerase chain reaction (PCR), mass spectrometry, microarray analysis, genomics, statistical analysis, and DNA sequencing are the sub-segments that make up the biomarker discovery process. Instruments for proteomics, microarray analysis, bead-based analysis, and real-time PCR are the sub-categories that fall under the umbrella of pathway analysis. The end-user category is comprised of a variety of entities, including but not limited to hospitals and clinics, clinical research facilities, biotechnology and pharmaceutical businesses, and government and academic institutions. Because of the growing number of people receiving training in genetic research, it is anticipated that biotechnology and pharmaceutical businesses would end up dominating the industry.

The report provides a company market share analysis to give a broader overview of the key players in the genomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the genomics market on a global and regional basis.

Genomics Market: Competitive Analysis

Some key players in the global genomics market are 

• Illumina. Inc.
• Thermo Fisher Scientific. Inc.
• QIAGEN N.V.
• Eurofins Scientific
• Agilent Technologies. Inc.
• GE Healthcare
• BGI
• Bio-Rad Laboratories. Inc.
• Oxford Nanopore Technologies
• F. Hoffmann-La Roche Ltd.
• And others

This report segments the global genomics market as follows:

Global Genomics Market: By Deliverables

• Services
  • NGS-Based
  • Core Genomics
  • Computational
  • Biomarker Translation
  • Others
• Products
  • Reagents
  • Instruments

Global Genomics Market: By Application

• Epigenomics
  • Chromatin Immunoprecipitation (ChIP-Seq)
  • Bisulfite Sequencing
  • Methylated DNA Immunoprecipitation (MeDIP)
  • Chromatin Accessibility Assays
  • High-Resolution Melt (HRM)
  • Microarray Analysis
• Functional
  • Real-Time PCR
  • Transfection
  • RNA Interference
  • SNP Analysis
  • Mutational Analysis
  • Microarray Analysis
• Biomarker Discovery
  • Real-Time PCR
  • Mass Spectrometry
  • Microarray Analysis
  • Bioinformatics
  • Statistical Analysis
  • DNA Sequencing
• Pathway Analysis
  • Microarray Analysis
  • Bead-Based Analysis
  • Real-Time PCR
  • Proteomics Tools
  • Others

Global Genomics Market: By End-User

• Government and Academic Institutes
• Clinical Research
• Biotechnology and Pharmaceutical Companies
• Hospitals and Clinics
• Others

Global Genomics Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• the Middle East and Africa